Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB17470ExperimentalVaccines
LP-2307 is an investigational allogeneic large multivalent immunogen (LMI) vaccine developed by Avanir. It was investigated for melanoma.
- Code names
- LP-2307
Which companies are running trials of LP-2307, in which indications and phases, and which of those programs are still active?